Global Infectious Diseases Molecular Diagnostics Market Research Report 2025(Status and Outlook)
Report Overview
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
The global Infectious Diseases Molecular Diagnostics market size was estimated at USD 10345.82 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Infectious Diseases Molecular Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Infectious Diseases Molecular Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Infectious Diseases Molecular Diagnostics market
Global Infectious Diseases Molecular Diagnostics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine
Market Segmentation (by Type)
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Market Segmentation (by Application)
Hospital
Third-party Testing Agency
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Diseases Molecular Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Infectious Diseases Molecular Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
The global Infectious Diseases Molecular Diagnostics market size was estimated at USD 10345.82 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Infectious Diseases Molecular Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Infectious Diseases Molecular Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Infectious Diseases Molecular Diagnostics market
Global Infectious Diseases Molecular Diagnostics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine
Market Segmentation (by Type)
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Market Segmentation (by Application)
Hospital
Third-party Testing Agency
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Infectious Diseases Molecular Diagnostics Market
- Overview of the regional outlook of the Infectious Diseases Molecular Diagnostics Market.
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Diseases Molecular Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Infectious Diseases Molecular Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Infectious Diseases Molecular Diagnostics
1.2 Key Market Segments
1.2.1 Infectious Diseases Molecular Diagnostics Segment by Type
1.2.2 Infectious Diseases Molecular Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Diseases Molecular Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Infectious Diseases Molecular Diagnostics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Infectious Diseases Molecular Diagnostics Product Life Cycle
3.3 Global Infectious Diseases Molecular Diagnostics Sales by Manufacturers (2020-2025)
3.4 Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Manufacturers (2020-2025)
3.5 Infectious Diseases Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Infectious Diseases Molecular Diagnostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Infectious Diseases Molecular Diagnostics Market Competitive Situation and Trends
3.8.1 Infectious Diseases Molecular Diagnostics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Infectious Diseases Molecular Diagnostics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Infectious Diseases Molecular Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Infectious Diseases Molecular Diagnostics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Infectious Diseases Molecular Diagnostics Market
5.7 ESG Ratings of Leading Companies
6 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Diseases Molecular Diagnostics Sales Market Share by Type (2020-2025)
6.3 Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2020-2025)
6.4 Global Infectious Diseases Molecular Diagnostics Price by Type (2020-2025)
7 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Diseases Molecular Diagnostics Market Sales by Application (2020-2025)
7.3 Global Infectious Diseases Molecular Diagnostics Market Size (M USD) by Application (2020-2025)
7.4 Global Infectious Diseases Molecular Diagnostics Sales Growth Rate by Application (2020-2025)
8 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET SALES BY REGION
8.1 Global Infectious Diseases Molecular Diagnostics Sales by Region
8.1.1 Global Infectious Diseases Molecular Diagnostics Sales by Region
8.1.2 Global Infectious Diseases Molecular Diagnostics Sales Market Share by Region
8.2 Global Infectious Diseases Molecular Diagnostics Market Size by Region
8.2.1 Global Infectious Diseases Molecular Diagnostics Market Size by Region
8.2.2 Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Region
8.3 North America
8.3.1 North America Infectious Diseases Molecular Diagnostics Sales by Country
8.3.2 North America Infectious Diseases Molecular Diagnostics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Infectious Diseases Molecular Diagnostics Sales by Country
8.4.2 Europe Infectious Diseases Molecular Diagnostics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Infectious Diseases Molecular Diagnostics Sales by Region
8.5.2 Asia Pacific Infectious Diseases Molecular Diagnostics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Infectious Diseases Molecular Diagnostics Sales by Country
8.6.2 South America Infectious Diseases Molecular Diagnostics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Infectious Diseases Molecular Diagnostics Sales by Region
8.7.2 Middle East and Africa Infectious Diseases Molecular Diagnostics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Infectious Diseases Molecular Diagnostics by Region(2020-2025)
9.2 Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Region (2020-2025)
9.3 Global Infectious Diseases Molecular Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Infectious Diseases Molecular Diagnostics Production
9.4.1 North America Infectious Diseases Molecular Diagnostics Production Growth Rate (2020-2025)
9.4.2 North America Infectious Diseases Molecular Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Infectious Diseases Molecular Diagnostics Production
9.5.1 Europe Infectious Diseases Molecular Diagnostics Production Growth Rate (2020-2025)
9.5.2 Europe Infectious Diseases Molecular Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Infectious Diseases Molecular Diagnostics Production (2020-2025)
9.6.1 Japan Infectious Diseases Molecular Diagnostics Production Growth Rate (2020-2025)
9.6.2 Japan Infectious Diseases Molecular Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Infectious Diseases Molecular Diagnostics Production (2020-2025)
9.7.1 China Infectious Diseases Molecular Diagnostics Production Growth Rate (2020-2025)
9.7.2 China Infectious Diseases Molecular Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Basic Information
10.1.2 Roche Infectious Diseases Molecular Diagnostics Product Overview
10.1.3 Roche Infectious Diseases Molecular Diagnostics Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Qiagen
10.2.1 Qiagen Basic Information
10.2.2 Qiagen Infectious Diseases Molecular Diagnostics Product Overview
10.2.3 Qiagen Infectious Diseases Molecular Diagnostics Product Market Performance
10.2.4 Qiagen Business Overview
10.2.5 Qiagen SWOT Analysis
10.2.6 Qiagen Recent Developments
10.3 Illumina
10.3.1 Illumina Basic Information
10.3.2 Illumina Infectious Diseases Molecular Diagnostics Product Overview
10.3.3 Illumina Infectious Diseases Molecular Diagnostics Product Market Performance
10.3.4 Illumina Business Overview
10.3.5 Illumina SWOT Analysis
10.3.6 Illumina Recent Developments
10.4 Abbott
10.4.1 Abbott Basic Information
10.4.2 Abbott Infectious Diseases Molecular Diagnostics Product Overview
10.4.3 Abbott Infectious Diseases Molecular Diagnostics Product Market Performance
10.4.4 Abbott Business Overview
10.4.5 Abbott Recent Developments
10.5 Hologic
10.5.1 Hologic Basic Information
10.5.2 Hologic Infectious Diseases Molecular Diagnostics Product Overview
10.5.3 Hologic Infectious Diseases Molecular Diagnostics Product Market Performance
10.5.4 Hologic Business Overview
10.5.5 Hologic Recent Developments
10.6 BioMerieux
10.6.1 BioMerieux Basic Information
10.6.2 BioMerieux Infectious Diseases Molecular Diagnostics Product Overview
10.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Product Market Performance
10.6.4 BioMerieux Business Overview
10.6.5 BioMerieux Recent Developments
10.7 Danaher (Cepheid)
10.7.1 Danaher (Cepheid) Basic Information
10.7.2 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product Overview
10.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product Market Performance
10.7.4 Danaher (Cepheid) Business Overview
10.7.5 Danaher (Cepheid) Recent Developments
10.8 Myriad Genetics
10.8.1 Myriad Genetics Basic Information
10.8.2 Myriad Genetics Infectious Diseases Molecular Diagnostics Product Overview
10.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Product Market Performance
10.8.4 Myriad Genetics Business Overview
10.8.5 Myriad Genetics Recent Developments
10.9 DAAN Gene
10.9.1 DAAN Gene Basic Information
10.9.2 DAAN Gene Infectious Diseases Molecular Diagnostics Product Overview
10.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Product Market Performance
10.9.4 DAAN Gene Business Overview
10.9.5 DAAN Gene Recent Developments
10.10 Agilent
10.10.1 Agilent Basic Information
10.10.2 Agilent Infectious Diseases Molecular Diagnostics Product Overview
10.10.3 Agilent Infectious Diseases Molecular Diagnostics Product Market Performance
10.10.4 Agilent Business Overview
10.10.5 Agilent Recent Developments
10.11 Genomic Health
10.11.1 Genomic Health Basic Information
10.11.2 Genomic Health Infectious Diseases Molecular Diagnostics Product Overview
10.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Product Market Performance
10.11.4 Genomic Health Business Overview
10.11.5 Genomic Health Recent Developments
10.12 BD
10.12.1 BD Basic Information
10.12.2 BD Infectious Diseases Molecular Diagnostics Product Overview
10.12.3 BD Infectious Diseases Molecular Diagnostics Product Market Performance
10.12.4 BD Business Overview
10.12.5 BD Recent Developments
10.13 Foundation Medicine
10.13.1 Foundation Medicine Basic Information
10.13.2 Foundation Medicine Infectious Diseases Molecular Diagnostics Product Overview
10.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Product Market Performance
10.13.4 Foundation Medicine Business Overview
10.13.5 Foundation Medicine Recent Developments
11 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET FORECAST BY REGION
11.1 Global Infectious Diseases Molecular Diagnostics Market Size Forecast
11.2 Global Infectious Diseases Molecular Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Infectious Diseases Molecular Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific Infectious Diseases Molecular Diagnostics Market Size Forecast by Region
11.2.4 South America Infectious Diseases Molecular Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Infectious Diseases Molecular Diagnostics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Infectious Diseases Molecular Diagnostics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Infectious Diseases Molecular Diagnostics by Type (2026-2033)
12.1.2 Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Infectious Diseases Molecular Diagnostics by Type (2026-2033)
12.2 Global Infectious Diseases Molecular Diagnostics Market Forecast by Application (2026-2033)
12.2.1 Global Infectious Diseases Molecular Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global Infectious Diseases Molecular Diagnostics Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Infectious Diseases Molecular Diagnostics
1.2 Key Market Segments
1.2.1 Infectious Diseases Molecular Diagnostics Segment by Type
1.2.2 Infectious Diseases Molecular Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Diseases Molecular Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Infectious Diseases Molecular Diagnostics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Infectious Diseases Molecular Diagnostics Product Life Cycle
3.3 Global Infectious Diseases Molecular Diagnostics Sales by Manufacturers (2020-2025)
3.4 Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Manufacturers (2020-2025)
3.5 Infectious Diseases Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Infectious Diseases Molecular Diagnostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Infectious Diseases Molecular Diagnostics Market Competitive Situation and Trends
3.8.1 Infectious Diseases Molecular Diagnostics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Infectious Diseases Molecular Diagnostics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Infectious Diseases Molecular Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Infectious Diseases Molecular Diagnostics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Infectious Diseases Molecular Diagnostics Market
5.7 ESG Ratings of Leading Companies
6 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Diseases Molecular Diagnostics Sales Market Share by Type (2020-2025)
6.3 Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2020-2025)
6.4 Global Infectious Diseases Molecular Diagnostics Price by Type (2020-2025)
7 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Diseases Molecular Diagnostics Market Sales by Application (2020-2025)
7.3 Global Infectious Diseases Molecular Diagnostics Market Size (M USD) by Application (2020-2025)
7.4 Global Infectious Diseases Molecular Diagnostics Sales Growth Rate by Application (2020-2025)
8 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET SALES BY REGION
8.1 Global Infectious Diseases Molecular Diagnostics Sales by Region
8.1.1 Global Infectious Diseases Molecular Diagnostics Sales by Region
8.1.2 Global Infectious Diseases Molecular Diagnostics Sales Market Share by Region
8.2 Global Infectious Diseases Molecular Diagnostics Market Size by Region
8.2.1 Global Infectious Diseases Molecular Diagnostics Market Size by Region
8.2.2 Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Region
8.3 North America
8.3.1 North America Infectious Diseases Molecular Diagnostics Sales by Country
8.3.2 North America Infectious Diseases Molecular Diagnostics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Infectious Diseases Molecular Diagnostics Sales by Country
8.4.2 Europe Infectious Diseases Molecular Diagnostics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Infectious Diseases Molecular Diagnostics Sales by Region
8.5.2 Asia Pacific Infectious Diseases Molecular Diagnostics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Infectious Diseases Molecular Diagnostics Sales by Country
8.6.2 South America Infectious Diseases Molecular Diagnostics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Infectious Diseases Molecular Diagnostics Sales by Region
8.7.2 Middle East and Africa Infectious Diseases Molecular Diagnostics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Infectious Diseases Molecular Diagnostics by Region(2020-2025)
9.2 Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Region (2020-2025)
9.3 Global Infectious Diseases Molecular Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Infectious Diseases Molecular Diagnostics Production
9.4.1 North America Infectious Diseases Molecular Diagnostics Production Growth Rate (2020-2025)
9.4.2 North America Infectious Diseases Molecular Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Infectious Diseases Molecular Diagnostics Production
9.5.1 Europe Infectious Diseases Molecular Diagnostics Production Growth Rate (2020-2025)
9.5.2 Europe Infectious Diseases Molecular Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Infectious Diseases Molecular Diagnostics Production (2020-2025)
9.6.1 Japan Infectious Diseases Molecular Diagnostics Production Growth Rate (2020-2025)
9.6.2 Japan Infectious Diseases Molecular Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Infectious Diseases Molecular Diagnostics Production (2020-2025)
9.7.1 China Infectious Diseases Molecular Diagnostics Production Growth Rate (2020-2025)
9.7.2 China Infectious Diseases Molecular Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Basic Information
10.1.2 Roche Infectious Diseases Molecular Diagnostics Product Overview
10.1.3 Roche Infectious Diseases Molecular Diagnostics Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Qiagen
10.2.1 Qiagen Basic Information
10.2.2 Qiagen Infectious Diseases Molecular Diagnostics Product Overview
10.2.3 Qiagen Infectious Diseases Molecular Diagnostics Product Market Performance
10.2.4 Qiagen Business Overview
10.2.5 Qiagen SWOT Analysis
10.2.6 Qiagen Recent Developments
10.3 Illumina
10.3.1 Illumina Basic Information
10.3.2 Illumina Infectious Diseases Molecular Diagnostics Product Overview
10.3.3 Illumina Infectious Diseases Molecular Diagnostics Product Market Performance
10.3.4 Illumina Business Overview
10.3.5 Illumina SWOT Analysis
10.3.6 Illumina Recent Developments
10.4 Abbott
10.4.1 Abbott Basic Information
10.4.2 Abbott Infectious Diseases Molecular Diagnostics Product Overview
10.4.3 Abbott Infectious Diseases Molecular Diagnostics Product Market Performance
10.4.4 Abbott Business Overview
10.4.5 Abbott Recent Developments
10.5 Hologic
10.5.1 Hologic Basic Information
10.5.2 Hologic Infectious Diseases Molecular Diagnostics Product Overview
10.5.3 Hologic Infectious Diseases Molecular Diagnostics Product Market Performance
10.5.4 Hologic Business Overview
10.5.5 Hologic Recent Developments
10.6 BioMerieux
10.6.1 BioMerieux Basic Information
10.6.2 BioMerieux Infectious Diseases Molecular Diagnostics Product Overview
10.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Product Market Performance
10.6.4 BioMerieux Business Overview
10.6.5 BioMerieux Recent Developments
10.7 Danaher (Cepheid)
10.7.1 Danaher (Cepheid) Basic Information
10.7.2 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product Overview
10.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product Market Performance
10.7.4 Danaher (Cepheid) Business Overview
10.7.5 Danaher (Cepheid) Recent Developments
10.8 Myriad Genetics
10.8.1 Myriad Genetics Basic Information
10.8.2 Myriad Genetics Infectious Diseases Molecular Diagnostics Product Overview
10.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Product Market Performance
10.8.4 Myriad Genetics Business Overview
10.8.5 Myriad Genetics Recent Developments
10.9 DAAN Gene
10.9.1 DAAN Gene Basic Information
10.9.2 DAAN Gene Infectious Diseases Molecular Diagnostics Product Overview
10.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Product Market Performance
10.9.4 DAAN Gene Business Overview
10.9.5 DAAN Gene Recent Developments
10.10 Agilent
10.10.1 Agilent Basic Information
10.10.2 Agilent Infectious Diseases Molecular Diagnostics Product Overview
10.10.3 Agilent Infectious Diseases Molecular Diagnostics Product Market Performance
10.10.4 Agilent Business Overview
10.10.5 Agilent Recent Developments
10.11 Genomic Health
10.11.1 Genomic Health Basic Information
10.11.2 Genomic Health Infectious Diseases Molecular Diagnostics Product Overview
10.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Product Market Performance
10.11.4 Genomic Health Business Overview
10.11.5 Genomic Health Recent Developments
10.12 BD
10.12.1 BD Basic Information
10.12.2 BD Infectious Diseases Molecular Diagnostics Product Overview
10.12.3 BD Infectious Diseases Molecular Diagnostics Product Market Performance
10.12.4 BD Business Overview
10.12.5 BD Recent Developments
10.13 Foundation Medicine
10.13.1 Foundation Medicine Basic Information
10.13.2 Foundation Medicine Infectious Diseases Molecular Diagnostics Product Overview
10.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Product Market Performance
10.13.4 Foundation Medicine Business Overview
10.13.5 Foundation Medicine Recent Developments
11 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET FORECAST BY REGION
11.1 Global Infectious Diseases Molecular Diagnostics Market Size Forecast
11.2 Global Infectious Diseases Molecular Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Infectious Diseases Molecular Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific Infectious Diseases Molecular Diagnostics Market Size Forecast by Region
11.2.4 South America Infectious Diseases Molecular Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Infectious Diseases Molecular Diagnostics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Infectious Diseases Molecular Diagnostics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Infectious Diseases Molecular Diagnostics by Type (2026-2033)
12.1.2 Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Infectious Diseases Molecular Diagnostics by Type (2026-2033)
12.2 Global Infectious Diseases Molecular Diagnostics Market Forecast by Application (2026-2033)
12.2.1 Global Infectious Diseases Molecular Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global Infectious Diseases Molecular Diagnostics Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Infectious Diseases Molecular Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Infectious Diseases Molecular Diagnostics Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Infectious Diseases Molecular Diagnostics Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Infectious Diseases Molecular Diagnostics Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Infectious Diseases Molecular Diagnostics Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases Molecular Diagnostics as of 2024)
Table 10. Global Market Infectious Diseases Molecular Diagnostics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Infectious Diseases Molecular Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Infectious Diseases Molecular Diagnostics Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Infectious Diseases Molecular Diagnostics Sales by Type (K Units)
Table 26. Global Infectious Diseases Molecular Diagnostics Market Size by Type (M USD)
Table 27. Global Infectious Diseases Molecular Diagnostics Sales (K Units) by Type (2020-2025)
Table 28. Global Infectious Diseases Molecular Diagnostics Sales Market Share by Type (2020-2025)
Table 29. Global Infectious Diseases Molecular Diagnostics Market Size (M USD) by Type (2020-2025)
Table 30. Global Infectious Diseases Molecular Diagnostics Market Size Share by Type (2020-2025)
Table 31. Global Infectious Diseases Molecular Diagnostics Price (USD/Unit) by Type (2020-2025)
Table 32. Global Infectious Diseases Molecular Diagnostics Sales (K Units) by Application
Table 33. Global Infectious Diseases Molecular Diagnostics Market Size by Application
Table 34. Global Infectious Diseases Molecular Diagnostics Sales by Application (2020-2025) & (K Units)
Table 35. Global Infectious Diseases Molecular Diagnostics Sales Market Share by Application (2020-2025)
Table 36. Global Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025) & (M USD)
Table 37. Global Infectious Diseases Molecular Diagnostics Market Share by Application (2020-2025)
Table 38. Global Infectious Diseases Molecular Diagnostics Sales Growth Rate by Application (2020-2025)
Table 39. Global Infectious Diseases Molecular Diagnostics Sales by Region (2020-2025) & (K Units)
Table 40. Global Infectious Diseases Molecular Diagnostics Sales Market Share by Region (2020-2025)
Table 41. Global Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 42. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Region (2020-2025)
Table 43. North America Infectious Diseases Molecular Diagnostics Sales by Country (2020-2025) & (K Units)
Table 44. North America Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Infectious Diseases Molecular Diagnostics Sales by Country (2020-2025) & (K Units)
Table 46. Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Infectious Diseases Molecular Diagnostics Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 49. South America Infectious Diseases Molecular Diagnostics Sales by Country (2020-2025) & (K Units)
Table 50. South America Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Infectious Diseases Molecular Diagnostics Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 53. Global Infectious Diseases Molecular Diagnostics Production (K Units) by Region(2020-2025)
Table 54. Global Infectious Diseases Molecular Diagnostics Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Region (2020-2025)
Table 56. Global Infectious Diseases Molecular Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Infectious Diseases Molecular Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Infectious Diseases Molecular Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Infectious Diseases Molecular Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Infectious Diseases Molecular Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Roche Basic Information
Table 62. Roche Infectious Diseases Molecular Diagnostics Product Overview
Table 63. Roche Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Roche Business Overview
Table 65. Roche SWOT Analysis
Table 66. Roche Recent Developments
Table 67. Qiagen Basic Information
Table 68. Qiagen Infectious Diseases Molecular Diagnostics Product Overview
Table 69. Qiagen Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Qiagen Business Overview
Table 71. Qiagen SWOT Analysis
Table 72. Qiagen Recent Developments
Table 73. Illumina Basic Information
Table 74. Illumina Infectious Diseases Molecular Diagnostics Product Overview
Table 75. Illumina Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Illumina Business Overview
Table 77. Illumina SWOT Analysis
Table 78. Illumina Recent Developments
Table 79. Abbott Basic Information
Table 80. Abbott Infectious Diseases Molecular Diagnostics Product Overview
Table 81. Abbott Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Abbott Business Overview
Table 83. Abbott Recent Developments
Table 84. Hologic Basic Information
Table 85. Hologic Infectious Diseases Molecular Diagnostics Product Overview
Table 86. Hologic Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Hologic Business Overview
Table 88. Hologic Recent Developments
Table 89. BioMerieux Basic Information
Table 90. BioMerieux Infectious Diseases Molecular Diagnostics Product Overview
Table 91. BioMerieux Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. BioMerieux Business Overview
Table 93. BioMerieux Recent Developments
Table 94. Danaher (Cepheid) Basic Information
Table 95. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product Overview
Table 96. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Danaher (Cepheid) Business Overview
Table 98. Danaher (Cepheid) Recent Developments
Table 99. Myriad Genetics Basic Information
Table 100. Myriad Genetics Infectious Diseases Molecular Diagnostics Product Overview
Table 101. Myriad Genetics Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Myriad Genetics Business Overview
Table 103. Myriad Genetics Recent Developments
Table 104. DAAN Gene Basic Information
Table 105. DAAN Gene Infectious Diseases Molecular Diagnostics Product Overview
Table 106. DAAN Gene Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. DAAN Gene Business Overview
Table 108. DAAN Gene Recent Developments
Table 109. Agilent Basic Information
Table 110. Agilent Infectious Diseases Molecular Diagnostics Product Overview
Table 111. Agilent Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Agilent Business Overview
Table 113. Agilent Recent Developments
Table 114. Genomic Health Basic Information
Table 115. Genomic Health Infectious Diseases Molecular Diagnostics Product Overview
Table 116. Genomic Health Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Genomic Health Business Overview
Table 118. Genomic Health Recent Developments
Table 119. BD Basic Information
Table 120. BD Infectious Diseases Molecular Diagnostics Product Overview
Table 121. BD Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. BD Business Overview
Table 123. BD Recent Developments
Table 124. Foundation Medicine Basic Information
Table 125. Foundation Medicine Infectious Diseases Molecular Diagnostics Product Overview
Table 126. Foundation Medicine Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Foundation Medicine Business Overview
Table 128. Foundation Medicine Recent Developments
Table 129. Global Infectious Diseases Molecular Diagnostics Sales Forecast by Region (2026-2033) & (K Units)
Table 130. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Region (2026-2033) & (M USD)
Table 131. North America Infectious Diseases Molecular Diagnostics Sales Forecast by Country (2026-2033) & (K Units)
Table 132. North America Infectious Diseases Molecular Diagnostics Market Size Forecast by Country (2026-2033) & (M USD)
Table 133. Europe Infectious Diseases Molecular Diagnostics Sales Forecast by Country (2026-2033) & (K Units)
Table 134. Europe Infectious Diseases Molecular Diagnostics Market Size Forecast by Country (2026-2033) & (M USD)
Table 135. Asia Pacific Infectious Diseases Molecular Diagnostics Sales Forecast by Region (2026-2033) & (K Units)
Table 136. Asia Pacific Infectious Diseases Molecular Diagnostics Market Size Forecast by Region (2026-2033) & (M USD)
Table 137. South America Infectious Diseases Molecular Diagnostics Sales Forecast by Country (2026-2033) & (K Units)
Table 138. South America Infectious Diseases Molecular Diagnostics Market Size Forecast by Country (2026-2033) & (M USD)
Table 139. Middle East and Africa Infectious Diseases Molecular Diagnostics Sales Forecast by Country (2026-2033) & (Units)
Table 140. Middle East and Africa Infectious Diseases Molecular Diagnostics Market Size Forecast by Country (2026-2033) & (M USD)
Table 141. Global Infectious Diseases Molecular Diagnostics Sales Forecast by Type (2026-2033) & (K Units)
Table 142. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Type (2026-2033) & (M USD)
Table 143. Global Infectious Diseases Molecular Diagnostics Price Forecast by Type (2026-2033) & (USD/Unit)
Table 144. Global Infectious Diseases Molecular Diagnostics Sales (K Units) Forecast by Application (2026-2033)
Table 145. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Infectious Diseases Molecular Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Infectious Diseases Molecular Diagnostics Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Infectious Diseases Molecular Diagnostics Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Infectious Diseases Molecular Diagnostics Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Infectious Diseases Molecular Diagnostics Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases Molecular Diagnostics as of 2024)
Table 10. Global Market Infectious Diseases Molecular Diagnostics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Infectious Diseases Molecular Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Infectious Diseases Molecular Diagnostics Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Infectious Diseases Molecular Diagnostics Sales by Type (K Units)
Table 26. Global Infectious Diseases Molecular Diagnostics Market Size by Type (M USD)
Table 27. Global Infectious Diseases Molecular Diagnostics Sales (K Units) by Type (2020-2025)
Table 28. Global Infectious Diseases Molecular Diagnostics Sales Market Share by Type (2020-2025)
Table 29. Global Infectious Diseases Molecular Diagnostics Market Size (M USD) by Type (2020-2025)
Table 30. Global Infectious Diseases Molecular Diagnostics Market Size Share by Type (2020-2025)
Table 31. Global Infectious Diseases Molecular Diagnostics Price (USD/Unit) by Type (2020-2025)
Table 32. Global Infectious Diseases Molecular Diagnostics Sales (K Units) by Application
Table 33. Global Infectious Diseases Molecular Diagnostics Market Size by Application
Table 34. Global Infectious Diseases Molecular Diagnostics Sales by Application (2020-2025) & (K Units)
Table 35. Global Infectious Diseases Molecular Diagnostics Sales Market Share by Application (2020-2025)
Table 36. Global Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025) & (M USD)
Table 37. Global Infectious Diseases Molecular Diagnostics Market Share by Application (2020-2025)
Table 38. Global Infectious Diseases Molecular Diagnostics Sales Growth Rate by Application (2020-2025)
Table 39. Global Infectious Diseases Molecular Diagnostics Sales by Region (2020-2025) & (K Units)
Table 40. Global Infectious Diseases Molecular Diagnostics Sales Market Share by Region (2020-2025)
Table 41. Global Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 42. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Region (2020-2025)
Table 43. North America Infectious Diseases Molecular Diagnostics Sales by Country (2020-2025) & (K Units)
Table 44. North America Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Infectious Diseases Molecular Diagnostics Sales by Country (2020-2025) & (K Units)
Table 46. Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Infectious Diseases Molecular Diagnostics Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 49. South America Infectious Diseases Molecular Diagnostics Sales by Country (2020-2025) & (K Units)
Table 50. South America Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Infectious Diseases Molecular Diagnostics Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 53. Global Infectious Diseases Molecular Diagnostics Production (K Units) by Region(2020-2025)
Table 54. Global Infectious Diseases Molecular Diagnostics Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Region (2020-2025)
Table 56. Global Infectious Diseases Molecular Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Infectious Diseases Molecular Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Infectious Diseases Molecular Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Infectious Diseases Molecular Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Infectious Diseases Molecular Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Roche Basic Information
Table 62. Roche Infectious Diseases Molecular Diagnostics Product Overview
Table 63. Roche Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Roche Business Overview
Table 65. Roche SWOT Analysis
Table 66. Roche Recent Developments
Table 67. Qiagen Basic Information
Table 68. Qiagen Infectious Diseases Molecular Diagnostics Product Overview
Table 69. Qiagen Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Qiagen Business Overview
Table 71. Qiagen SWOT Analysis
Table 72. Qiagen Recent Developments
Table 73. Illumina Basic Information
Table 74. Illumina Infectious Diseases Molecular Diagnostics Product Overview
Table 75. Illumina Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Illumina Business Overview
Table 77. Illumina SWOT Analysis
Table 78. Illumina Recent Developments
Table 79. Abbott Basic Information
Table 80. Abbott Infectious Diseases Molecular Diagnostics Product Overview
Table 81. Abbott Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Abbott Business Overview
Table 83. Abbott Recent Developments
Table 84. Hologic Basic Information
Table 85. Hologic Infectious Diseases Molecular Diagnostics Product Overview
Table 86. Hologic Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Hologic Business Overview
Table 88. Hologic Recent Developments
Table 89. BioMerieux Basic Information
Table 90. BioMerieux Infectious Diseases Molecular Diagnostics Product Overview
Table 91. BioMerieux Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. BioMerieux Business Overview
Table 93. BioMerieux Recent Developments
Table 94. Danaher (Cepheid) Basic Information
Table 95. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product Overview
Table 96. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Danaher (Cepheid) Business Overview
Table 98. Danaher (Cepheid) Recent Developments
Table 99. Myriad Genetics Basic Information
Table 100. Myriad Genetics Infectious Diseases Molecular Diagnostics Product Overview
Table 101. Myriad Genetics Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Myriad Genetics Business Overview
Table 103. Myriad Genetics Recent Developments
Table 104. DAAN Gene Basic Information
Table 105. DAAN Gene Infectious Diseases Molecular Diagnostics Product Overview
Table 106. DAAN Gene Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. DAAN Gene Business Overview
Table 108. DAAN Gene Recent Developments
Table 109. Agilent Basic Information
Table 110. Agilent Infectious Diseases Molecular Diagnostics Product Overview
Table 111. Agilent Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Agilent Business Overview
Table 113. Agilent Recent Developments
Table 114. Genomic Health Basic Information
Table 115. Genomic Health Infectious Diseases Molecular Diagnostics Product Overview
Table 116. Genomic Health Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Genomic Health Business Overview
Table 118. Genomic Health Recent Developments
Table 119. BD Basic Information
Table 120. BD Infectious Diseases Molecular Diagnostics Product Overview
Table 121. BD Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. BD Business Overview
Table 123. BD Recent Developments
Table 124. Foundation Medicine Basic Information
Table 125. Foundation Medicine Infectious Diseases Molecular Diagnostics Product Overview
Table 126. Foundation Medicine Infectious Diseases Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Foundation Medicine Business Overview
Table 128. Foundation Medicine Recent Developments
Table 129. Global Infectious Diseases Molecular Diagnostics Sales Forecast by Region (2026-2033) & (K Units)
Table 130. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Region (2026-2033) & (M USD)
Table 131. North America Infectious Diseases Molecular Diagnostics Sales Forecast by Country (2026-2033) & (K Units)
Table 132. North America Infectious Diseases Molecular Diagnostics Market Size Forecast by Country (2026-2033) & (M USD)
Table 133. Europe Infectious Diseases Molecular Diagnostics Sales Forecast by Country (2026-2033) & (K Units)
Table 134. Europe Infectious Diseases Molecular Diagnostics Market Size Forecast by Country (2026-2033) & (M USD)
Table 135. Asia Pacific Infectious Diseases Molecular Diagnostics Sales Forecast by Region (2026-2033) & (K Units)
Table 136. Asia Pacific Infectious Diseases Molecular Diagnostics Market Size Forecast by Region (2026-2033) & (M USD)
Table 137. South America Infectious Diseases Molecular Diagnostics Sales Forecast by Country (2026-2033) & (K Units)
Table 138. South America Infectious Diseases Molecular Diagnostics Market Size Forecast by Country (2026-2033) & (M USD)
Table 139. Middle East and Africa Infectious Diseases Molecular Diagnostics Sales Forecast by Country (2026-2033) & (Units)
Table 140. Middle East and Africa Infectious Diseases Molecular Diagnostics Market Size Forecast by Country (2026-2033) & (M USD)
Table 141. Global Infectious Diseases Molecular Diagnostics Sales Forecast by Type (2026-2033) & (K Units)
Table 142. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Type (2026-2033) & (M USD)
Table 143. Global Infectious Diseases Molecular Diagnostics Price Forecast by Type (2026-2033) & (USD/Unit)
Table 144. Global Infectious Diseases Molecular Diagnostics Sales (K Units) Forecast by Application (2026-2033)
Table 145. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Infectious Diseases Molecular Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Diseases Molecular Diagnostics Market Size (M USD), 2024-2033
Figure 5. Global Infectious Diseases Molecular Diagnostics Market Size (M USD) (2020-2033)
Figure 6. Global Infectious Diseases Molecular Diagnostics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Diseases Molecular Diagnostics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Infectious Diseases Molecular Diagnostics Product Life Cycle
Figure 13. Infectious Diseases Molecular Diagnostics Sales Share by Manufacturers in 2024
Figure 14. Global Infectious Diseases Molecular Diagnostics Revenue Share by Manufacturers in 2024
Figure 15. Infectious Diseases Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Infectious Diseases Molecular Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Infectious Diseases Molecular Diagnostics Revenue in 2024
Figure 18. Industry Chain Map of Infectious Diseases Molecular Diagnostics
Figure 19. Global Infectious Diseases Molecular Diagnostics Market PEST Analysis
Figure 20. Global Infectious Diseases Molecular Diagnostics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Infectious Diseases Molecular Diagnostics Market Share by Type
Figure 27. Sales Market Share of Infectious Diseases Molecular Diagnostics by Type (2020-2025)
Figure 28. Sales Market Share of Infectious Diseases Molecular Diagnostics by Type in 2024
Figure 29. Market Size Share of Infectious Diseases Molecular Diagnostics by Type (2020-2025)
Figure 30. Market Size Share of Infectious Diseases Molecular Diagnostics by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Infectious Diseases Molecular Diagnostics Market Share by Application
Figure 33. Global Infectious Diseases Molecular Diagnostics Sales Market Share by Application (2020-2025)
Figure 34. Global Infectious Diseases Molecular Diagnostics Sales Market Share by Application in 2024
Figure 35. Global Infectious Diseases Molecular Diagnostics Market Share by Application (2020-2025)
Figure 36. Global Infectious Diseases Molecular Diagnostics Market Share by Application in 2024
Figure 37. Global Infectious Diseases Molecular Diagnostics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Infectious Diseases Molecular Diagnostics Sales Market Share by Region (2020-2025)
Figure 39. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Region (2020-2025)
Figure 40. North America Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Infectious Diseases Molecular Diagnostics Sales Market Share by Country in 2024
Figure 43. North America Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Infectious Diseases Molecular Diagnostics Market Size Market Share by Country in 2024
Figure 45. U.S. Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Infectious Diseases Molecular Diagnostics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Infectious Diseases Molecular Diagnostics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Infectious Diseases Molecular Diagnostics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Infectious Diseases Molecular Diagnostics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Infectious Diseases Molecular Diagnostics Sales Market Share by Country in 2024
Figure 53. Europe Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Country in 2024
Figure 55. Germany Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Infectious Diseases Molecular Diagnostics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Infectious Diseases Molecular Diagnostics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Infectious Diseases Molecular Diagnostics Market Size Market Share by Region in 2024
Figure 68. China Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Infectious Diseases Molecular Diagnostics Sales and Growth Rate (K Units)
Figure 79. South America Infectious Diseases Molecular Diagnostics Sales Market Share by Country in 2024
Figure 80. South America Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (M USD)
Figure 81. South America Infectious Diseases Molecular Diagnostics Market Size Market Share by Country in 2024
Figure 82. Brazil Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Infectious Diseases Molecular Diagnostics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Infectious Diseases Molecular Diagnostics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Infectious Diseases Molecular Diagnostics Production Market Share by Region (2020-2025)
Figure 103. North America Infectious Diseases Molecular Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Infectious Diseases Molecular Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Infectious Diseases Molecular Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Infectious Diseases Molecular Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Infectious Diseases Molecular Diagnostics Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Infectious Diseases Molecular Diagnostics Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Infectious Diseases Molecular Diagnostics Market Share Forecast by Type (2026-2033)
Figure 111. Global Infectious Diseases Molecular Diagnostics Sales Forecast by Application (2026-2033)
Figure 112. Global Infectious Diseases Molecular Diagnostics Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Infectious Diseases Molecular Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Diseases Molecular Diagnostics Market Size (M USD), 2024-2033
Figure 5. Global Infectious Diseases Molecular Diagnostics Market Size (M USD) (2020-2033)
Figure 6. Global Infectious Diseases Molecular Diagnostics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Diseases Molecular Diagnostics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Infectious Diseases Molecular Diagnostics Product Life Cycle
Figure 13. Infectious Diseases Molecular Diagnostics Sales Share by Manufacturers in 2024
Figure 14. Global Infectious Diseases Molecular Diagnostics Revenue Share by Manufacturers in 2024
Figure 15. Infectious Diseases Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Infectious Diseases Molecular Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Infectious Diseases Molecular Diagnostics Revenue in 2024
Figure 18. Industry Chain Map of Infectious Diseases Molecular Diagnostics
Figure 19. Global Infectious Diseases Molecular Diagnostics Market PEST Analysis
Figure 20. Global Infectious Diseases Molecular Diagnostics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Infectious Diseases Molecular Diagnostics Market Share by Type
Figure 27. Sales Market Share of Infectious Diseases Molecular Diagnostics by Type (2020-2025)
Figure 28. Sales Market Share of Infectious Diseases Molecular Diagnostics by Type in 2024
Figure 29. Market Size Share of Infectious Diseases Molecular Diagnostics by Type (2020-2025)
Figure 30. Market Size Share of Infectious Diseases Molecular Diagnostics by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Infectious Diseases Molecular Diagnostics Market Share by Application
Figure 33. Global Infectious Diseases Molecular Diagnostics Sales Market Share by Application (2020-2025)
Figure 34. Global Infectious Diseases Molecular Diagnostics Sales Market Share by Application in 2024
Figure 35. Global Infectious Diseases Molecular Diagnostics Market Share by Application (2020-2025)
Figure 36. Global Infectious Diseases Molecular Diagnostics Market Share by Application in 2024
Figure 37. Global Infectious Diseases Molecular Diagnostics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Infectious Diseases Molecular Diagnostics Sales Market Share by Region (2020-2025)
Figure 39. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Region (2020-2025)
Figure 40. North America Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Infectious Diseases Molecular Diagnostics Sales Market Share by Country in 2024
Figure 43. North America Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Infectious Diseases Molecular Diagnostics Market Size Market Share by Country in 2024
Figure 45. U.S. Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Infectious Diseases Molecular Diagnostics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Infectious Diseases Molecular Diagnostics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Infectious Diseases Molecular Diagnostics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Infectious Diseases Molecular Diagnostics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Infectious Diseases Molecular Diagnostics Sales Market Share by Country in 2024
Figure 53. Europe Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Country in 2024
Figure 55. Germany Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Infectious Diseases Molecular Diagnostics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Infectious Diseases Molecular Diagnostics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Infectious Diseases Molecular Diagnostics Market Size Market Share by Region in 2024
Figure 68. China Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Infectious Diseases Molecular Diagnostics Sales and Growth Rate (K Units)
Figure 79. South America Infectious Diseases Molecular Diagnostics Sales Market Share by Country in 2024
Figure 80. South America Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (M USD)
Figure 81. South America Infectious Diseases Molecular Diagnostics Market Size Market Share by Country in 2024
Figure 82. Brazil Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Infectious Diseases Molecular Diagnostics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Infectious Diseases Molecular Diagnostics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Infectious Diseases Molecular Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Infectious Diseases Molecular Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Infectious Diseases Molecular Diagnostics Production Market Share by Region (2020-2025)
Figure 103. North America Infectious Diseases Molecular Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Infectious Diseases Molecular Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Infectious Diseases Molecular Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Infectious Diseases Molecular Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Infectious Diseases Molecular Diagnostics Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Infectious Diseases Molecular Diagnostics Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Infectious Diseases Molecular Diagnostics Market Share Forecast by Type (2026-2033)
Figure 111. Global Infectious Diseases Molecular Diagnostics Sales Forecast by Application (2026-2033)
Figure 112. Global Infectious Diseases Molecular Diagnostics Market Share Forecast by Application (2026-2033)
